An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas
<p>Abstract</p> <p>Background</p> <p>In ovarian cancer, the reported rate of EGFR expression varies between 4-70% depending on assessment method and data on patient outcome are conflicting. Methods: In this study we investigated EGFR expression and its prognostic value...
Main Authors: | Braicu Elena I, Sehouli Jalid, Buckendahl Ann-Christin, Darb-Esfahani Silvia, Weichert Wilko, Schwabe Michael, Noske Aurelia, Budczies Jan, Dietel Manfred, Denkert Carsten |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/294 |
Similar Items
-
EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
by: Arafa Musa, et al.
Published: (2022-02-01) -
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors
by: Belgin Sever, et al.
Published: (2020-11-01) -
Investigating Cox-2 and EGFR as Biomarkers in Canine Oral Squamous Cell Carcinoma: Implications for Diagnosis and Therapy
by: Rita Files, et al.
Published: (2024-01-01) -
New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies
by: Wael A. A. Fadaly, et al.
Published: (2023-12-01) -
Rancang Bangun Electronic Customer Relationship Management pada Sistem Informasi Hotel dengan Framework of Dynamic CRM
by: Siti Monalisa, et al.
Published: (2020-02-01)